These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 23220975)

  • 1. A comparison of the use of traditional hand injection versus automated contrast injectors during cardiac catheterization.
    Godley RW; Joshi K; Breall JA
    J Invasive Cardiol; 2012 Dec; 24(12):628-30. PubMed ID: 23220975
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Automated contrast injection in contemporary practice during cardiac catheterization and PCI: effects on contrast-induced nephropathy.
    Call J; Sacrinty M; Applegate R; Little W; Santos R; Baki T; Gandhi S; Kahl F; Kutcher M
    J Invasive Cardiol; 2006 Oct; 18(10):469-74. PubMed ID: 17042103
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Traditional versus automated injection contrast system in diagnostic and percutaneous coronary interventional procedures: comparison of the contrast volume delivered.
    Anne G; Gruberg L; Huber A; Nikolsky E; Grenadier E; Boulus M; Amikam S; Markiewicz W; Beyar R
    J Invasive Cardiol; 2004 Jul; 16(7):360-2. PubMed ID: 15282428
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Contrast volume use in manual vs automated contrast injection systems for diagnostic coronary angiography and percutaneous coronary interventions.
    Hwang JR; D'Alfonso S; Kostuk WJ; Diamantouros P; Teefy P; Jablonsky G; Lavi S
    Can J Cardiol; 2013 Mar; 29(3):372-6. PubMed ID: 23352426
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Impact of automated contrast injector systems on contrast use and contrast-associated complications in patients undergoing percutaneous coronary interventions.
    Gurm HS; Smith D; Share D; Wohns D; Collins J; Madala M; Koneru S; Menees D; Chetcuti S
    JACC Cardiovasc Interv; 2013 Apr; 6(4):399-405. PubMed ID: 23523450
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prediction of contrast-induced nephropathy in diabetic patients undergoing elective cardiac catheterization or PCI: role of volume-to-creatinine clearance ratio and iodine dose-to-creatinine clearance ratio.
    Worasuwannarak S; Pornratanarangsi S
    J Med Assoc Thai; 2010 Jan; 93 Suppl 1():S29-34. PubMed ID: 20364554
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Trends in vascular complications after diagnostic cardiac catheterization and percutaneous coronary intervention via the femoral artery, 1998 to 2007.
    Applegate RJ; Sacrinty MT; Kutcher MA; Kahl FR; Gandhi SK; Santos RM; Little WC
    JACC Cardiovasc Interv; 2008 Jun; 1(3):317-26. PubMed ID: 19463320
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Qualitative comparison of coronary angiograms between 4 French catheters with an advanced cardiovascular injection system and 6 French catheters with manual injection.
    Gonzalez MA; Ben-Dor I; Gaglia MA; Torguson R; Shimellis H; Bui A; Suddath WO; Pichard AD; Satler LF; Waksman R
    Catheter Cardiovasc Interv; 2012 Apr; 79(5):843-8. PubMed ID: 21805567
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Reduction in Contrast Nephropathy From Coronary Angiography and Percutaneous Coronary Intervention With Ultra-Low Contrast Delivery Using an Automated Contrast Injector System.
    Kelly SC; Li S; Stys TP; Thompson PA; Stys AT
    J Invasive Cardiol; 2016 Nov; 28(11):446-450. PubMed ID: 27430665
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Angiotensin-converting enzyme inhibitors and their effects on contrast-induced nephropathy after cardiac catheterization or percutaneous coronary intervention.
    Patel K; King CA; Jovin IS
    Cardiovasc Revasc Med; 2011; 12(2):90-3. PubMed ID: 21421186
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The impact of iso-osmolar contrast use in emergent percutaneous coronary intervention for ST-segment elevation myocardial infarction.
    Kanei Y; Ayabe K; Ratcliffe J; Vales L; Nakra N; Friedman P; Fox J
    J Invasive Cardiol; 2011 Nov; 23(11):448-50. PubMed ID: 22045075
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Impact of gender on the incidence and outcome of contrast-induced nephropathy after percutaneous coronary intervention.
    Iakovou I; Dangas G; Mehran R; Lansky AJ; Ashby DT; Fahy M; Mintz GS; Kent KM; Pichard AD; Satler LF; Stone GW; Leon MB
    J Invasive Cardiol; 2003 Jan; 15(1):18-22. PubMed ID: 12499523
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Contrast nephropathy in high-risk patients undergoing coronary angiography and intervention.
    Uddin MA; Rabbani MA; Jafary FH; Bhatti MA; Islam M
    J Coll Physicians Surg Pak; 2005 Dec; 15(12):791-4. PubMed ID: 16398973
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Contrast-induced nephropathy and risk of acute kidney injury and mortality after cardiac operations.
    Garcia S; Ko B; Adabag S
    Ann Thorac Surg; 2012 Sep; 94(3):772-6. PubMed ID: 22835553
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prediction of contrast-induced nephropathy in diabetics undergoing elective percutaneous coronary intervention: role of the ratio of contrast medium volume to estimated glomerular filtration rate.
    Wang XC; Fu XH; Wang YB; Jia XW; Wu WL; Gu XS; Zhang J; Su JL; Hao GZ; Jiang YF; Fan WZ; Li SQ
    Chin Med J (Engl); 2011 Mar; 124(6):892-6. PubMed ID: 21518598
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Statins for prevention of contrast-induced nephropathy in patients undergoing non-emergent percutaneous coronary intervention.
    Kandula P; Shah R; Singh N; Markwell SJ; Bhensdadia N; Navaneethan SD
    Nephrology (Carlton); 2010 Mar; 15(2):165-70. PubMed ID: 20470274
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Meta-analysis of the effect of automated contrast injection devices versus manual injection and contrast volume on risk of contrast-induced nephropathy.
    Minsinger KD; Kassis HM; Block CA; Sidhu M; Brown JR
    Am J Cardiol; 2014 Jan; 113(1):49-53. PubMed ID: 24188890
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Contrast-induced nephropathy among Israeli hospitalized patients: incidence, risk factors, length of stay and mortality.
    Shema L; Ore L; Geron R; Kristal B
    Isr Med Assoc J; 2009 Aug; 11(8):460-4. PubMed ID: 19891232
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Contrast-induced nephropathy after percutaneous coronary interventions in relation to chronic kidney disease and hemodynamic variables.
    Dangas G; Iakovou I; Nikolsky E; Aymong ED; Mintz GS; Kipshidze NN; Lansky AJ; Moussa I; Stone GW; Moses JW; Leon MB; Mehran R
    Am J Cardiol; 2005 Jan; 95(1):13-9. PubMed ID: 15619387
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Prevention of contrast-induced nephropathy using cardiac catheterization combined with hydration, oral N-acetylcysteine, sodium bicarbonate and iso-osmolar contrast agents].
    Hoshino A; Enomoto S; Kawahito H; Kurata H; Nakahara Y; Nakamura T
    J Cardiol; 2007 Aug; 50(2):119-26. PubMed ID: 17802695
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.